Akhil Abraham Saji, MD

Akhil Abraham Saji, MD, is a urology resident at New York Medical College/Westchester Medical Center. His interests include urology education and machine learning applications in urologic care. He is a founding and current member of the EMPIRE urology lecture series developed by the American Urological Association New York section.

Articles by Akhil Abraham Saji, MD

Akhil Abraham Saji, MDAUA 2023 | May 31, 2023
One might assume that the AUA meeting is geared toward practicing urologists, but it is also crucial for urologic trainees.
Read More
Akhil Abraham Saji, MDLocalized Prostate Cancer | May 30, 2023
The postsurgical treatment of functional outcomes such as UI and ED after SRP remains a challenge for all urologists.
Akhil Abraham Saji, MDNon-Muscle Invasive Urothelial Carcinoma | May 30, 2023
FDA approval of Adstiladrin for use in BCG-unresponsive nMIBC expands the armamentarium for treatment of high-risk nMIBC.
David Ambinder, MDAUA 2023 | May 2, 2023
Drs. David Ambinder and Akhil Saji highlight the importance of attending the AUA meeting as urology residents.
Akhil Abraham Saji, MDNon-Muscle Invasive Urothelial Carcinoma | May 1, 2023
NMIBC-associated costs vary widely across types of treatments utilized, health systems, and regions of the country.
Akhil Abraham Saji, MDMuscle Invasive Urothelial Carcinoma | May 1, 2023
The minimally invasive options available to patients diagnosed with muscle-invasive disease of urothelial origin are limited.
Akhil Abraham Saji, MDProstate Cancer | March 31, 2023
This review highlights the existing research regarding the financial toxicity of advanced prostate cancer.
Akhil Abraham Saji, MDAUA 2023 | March 30, 2023
This review highlights the upcoming plenary sessions of importance in prostate, bladder, kidney, and testicular cancer.
Akhil Abraham Saji, MDLocalized Renal Cell Carcinoma | March 30, 2023
AUA guidelines for localized RCC have thermal ablation as an alternative modality. EAU guidelines are conflicting.
Akhil Abraham Saji, MDProstate Cancer | March 10, 2023
Mutahar Ahmed, MD, discusses the history and current applications of single-port robotic surgery in prostate cancer.
Akhil Abraham Saji, MDLocalized Prostate Cancer | February 28, 2023
This review highlights the research on the costs related to the treatment of localized PC and the associated outcomes.
Akhil Abraham Saji, MDNon-Muscle Invasive Urothelial Carcinoma | February 24, 2023
BCG plus nogapendekin alfa inbakicept may offer an enhanced treatment option for patients with high-risk NMIBC.
Akhil Abraham Saji, MDProstate Cancer | January 13, 2023
A review of the GÖTEBORG-2 trial and the current recommendations for utilizing mpMRI in prostate cancer screening, ...
Akhil Abraham Saji, MDUrothelial Carcinoma | January 13, 2023
An investigation and review of both studies regarding their differences, similarities, and conclusions.
Akhil Abraham Saji, MDProstate Cancer | January 13, 2023
The evidence regarding bisphosphate and denosumab therapy and the impact that bone-protective agents can have on patients.
Akhil Abraham Saji, MDJournal | December 19, 2022
At the ASTRO 2022 meeting, several authors presented abstracts on postprostatectomy radiation that are worth reviewing.
Akhil Abraham Saji, MDJournal | December 19, 2022
A detail of the analgesic modalities available for treatment of patients undergoing minimally-invasive urologic surgery.
Akhil Abraham Saji, MDJournal | December 19, 2022
ASTRO 2022 included several interesting articles about genitourinary cancers, including prostate cancer and bladder cancer.
Akhil Abraham Saji, MDJournal | November 22, 2022
Stereotactic body radiotherapy can benefit RCC patients deemed unfit for surgical therapy.
Akhil Abraham Saji, MDJournal | November 22, 2022
1 of 4 will UTUC patients will have a variant histologic subtype such as squamous cell, micropapillary, or neuroendocrine.